what is known already: The aim of reproductive medicine is to assist subfertile couples in their wish to have children. A decade ago it was proposed to use singleton live birth as the outcome measure. We assessed whether clinical research has followed this recommendation, and how neonatal/maternal outcomes are reported. limitations, reasons for caution: We only included Cochrane reviews, thus report here only on the higher quality studies. The actual reporting on maternal and neonatal outcome may even be lower when studies of lower quality are included.
Introduction
The aim of reproductive medicine is to assist couples with an unfulfilled child wish to have a healthy child, or, if wanted, healthy children. A major breakthrough in the field of reproductive medicine has been the introduction of IVF.
In the early years of IVF success rates were low; therefore, the transfer of multiple embryos was introduced. After the initial years of increasing success rates, concerns were raised about the safety of multiple embryo transfer, particularly in view of the high rate of multiple pregnancies (Schieve et al., 1999) . Multiple pregnancies are known to have a higher risk of complications for both mother and offspring. Women are more at risk for developing pre-eclampsia and labour complications requiring Caesarean section (Campbell and Templeton, 2004) . Children born from multiple pregnancies have an increased chance of being growth restricted or being born preterm (ESHRE Capri Workshop Group et al., 2000) .
In view of these concerns, the outcome measures that should be used to assess the effectiveness of assisted reproduction techniques (ART) are a frequently discussed subject.
In 2003, during a European Society for Human Reproduction and Embryology (ESHRE) consensus meeting, it was agreed that although ART is applied on a large scale in Europe, risks and complications are poorly documented. Therefore, the outcome measure of ART and non-ART should be singleton live birth, and multiple pregnancies should thereby be regarded as a complication. It was also recommended that registries should include data on neonatal and maternal morbidity and mortality (Land and Evers, 2003) .
This recommendation fuelled a fundamental debate series on the most relevant standard of success in assisted reproduction. Proposed outcomes varied from singleton live birth per cycle initiated (Wennerholm and Bergh, 2004) and birth emphasizing a successful singleton at term (Min et al., 2004) to the percentage of elective single embryo transfer (Land and Evers, 2004) and delivery rates per oocyte retrieved (Germond et al., 2004) . This debate never led to new recommendations and as such it would seem that singleton live birth is currently the accepted outcome measurement. What we do not know however is whether this outcome measure is indeed reported in the current literature.
The aim of this review was therefore to determine whether the recommended outcome measure 'singleton live birth' is used as the outcome measure in subfertility trials. In addition, we assessed whether studies report on neonatal and maternal morbidity and mortality.
Materials and Methods

Search strategy
The database of the Cochrane Menstrual Disorders and Subfertility Group was searched for systematic reviews on interventions in reproductive medicine. In June 2013 all identified reviews were screened by two reviewers (M.M.v.R. and M.B.) and selected by title. The selected systematic reviews were categorized as reporting on IVF, ICSI, intrauterine insemination (IUI), ovulation induction (OI) or other reproductive treatments, for example tubal surgery or acupuncture.
Inclusion and exclusion criteria
We included all randomised controlled trials (RCTs) reported in these reviews. If an RCT was included in more than one review, data were only listed once.
Analysis
All included RCTs were searched for reporting of singleton live birth as outcome measure, or a descriptive form of singleton live birth, i.e. 'healthy singletons' or 'take home baby rate' when differentiated between singleton and multiple pregnancies. If one of these outcomes was mentioned, the RCT was evaluated in detail with respect to neonatal (after achieving ongoing pregnancy) and maternal outcome. We did not list data on miscarriages and early pregnancy loss. Stratification of the studies on year of publication was performed to register whether a change took place in reporting on singleton live birth after the ESHRE consensus report in 2003. We chose to compare the reporting on neonatal/maternal outcome in the periods before and after 2004, since this was the year after the ESHRE recommendation was published.
To compare data from the various studies we used definitions that were provided in the International Committee for Monitoring Assisted Reproductive Technology (ICMART) glossary (Zegers Hochschild et al., 2009) . In this glossary, singleton live birth is defined as a pregnancy that resulted in the birth of at least one baby born alive, independent of gestational age. Preterm birth is defined as a live birth or stillbirth that occurred after at least 20, but before 37, completed weeks of gestation. Congenital anomalies are defined as all structural, functional, and genetic anomalies diagnosed in aborted fetuses, at birth, or in the neonatal period. Neonatal complications in general are not defined in the ICMART glossary and we therefore listed all neonatal outcomes that were available from the publications: gestational age, congenital anomalies, low birthweight, intrauterine growth restriction and perinatal death.
Results
Search strategy
Our search of the Cochrane database identified 87 reviews comparing clinical trials in the field of reproductive medicine, summarizing 910 RCTs. In total, 182 out of 910 RCTs (20%) reported on singleton live birth. These RCTs were searched for further information on neonatal and maternal outcome. An overview of ratio between RCTs reporting on-and not reporting on singleton live birth, neonatal and maternal outcome is provided in Fig. 1 .
RCTs published before and after 2004
Out of the 910 RCTs evaluated for this review, 518 were published before January 2004, of which 96 RCTs (19%) reported on singleton live birth and 30 RCTs used singleton live birth as primary outcome measure (6%). Of the total 910 RCTs, 392 were published after December 2003, of which 86 (22%) reported on singleton live birth. As a primary outcome, singleton live birth was reported in 38 studies (10%).
Results on IVF/ICSI trials
There were 555 RCTs that reported on IVF or ICSI of which 126 (23%) reported on singleton live birth. A detailed overview is provided in Table I The use of singleton live birth as outcome reported in RCTs (9%). Neonatal outcome was only mentioned in 25 RCTs (4.5%). Maternal outcome was mentioned in 34 RCTs (6.1%), most trials only reported on ovarian hyperstimulation syndrome.
Results on IUI trials
There were 159 RCTs that reported on IUI, of which 28 (18%) reported on singleton live birth. A detailed overview is provided in Table II . Singleton live birth was the primary outcome in nine studies (6%). Neonatal outcome was reported in 9 RCTs (5.7%), while 10 RCTs (6.3%) reported maternal outcome.
Results on OI trials
Out of the 57 trials that reported on OI, 12 reported on singleton live birth (21%). A detailed overview is provided in Table III . Singleton live birth was the primary outcome in five studies (9%). Only three studies (5.3%) reported on neonatal outcome and six studies (10.5%) reported on maternal outcome.
Results on other reproductive treatment trials
Out of the 139 RCTs that reported on other interventions, 16 reported on singleton live birth (12%). A detailed overview is provided in Table IV .
Singleton live birth was the primary outcome in five studies (4%). Only seven studies (5.0%) reported neonatal outcome. Two studies (1.4%) reported on maternal outcome.
Discussion
We aimed to evaluate the use of singleton live birth as an outcome measure in reproductive medicine trials, both before and after this had been recommended by ESHRE in 2003. Our review shows that singleton live birth as an outcome measure in reproductive medicine trials is implemented in a minority of the RCTs. From 2004 22% of the published studies used singleton live birth as outcome measure, when compared with 19% of the studies before 2004. Although we found a rise in reporting singleton live birth in trials on IUI and OI, this had limited impact in view of the large number of trials on IVF/ICSI. We also found minimal reporting on neonatal and maternal outcome. Although there is no general recommendation to report on the outcome, records of safety parameters in RCTs can be useful when differentiating between several treatment options. Thereby it is clear that final conclusions on safety should be based on cohort studies. 
Limitations
We realize that using Cochrane reviews carries the risk of selection bias; not all trials are included in Cochrane reviews. However, we feel that if such a selection would be present, it would have led to selection of the higher quality studies. We therefore think that our approach contains the appropriate studies, representing the randomized studies of the highest quality in reproductive medicine, i.e. those most likely to change clinical practice. The reporting rate of neonatal and maternal outcomes might even be lower if lower quality studies were included.
Strengths
Our review evaluates a large number of trials, which resulted in an accurate overview of the outcomes used in trials on reproductive medicine. This review indicates that there is a large heterogeneity between outcome measures reported in clinical trials in reproductive medicine. Comparisons between trials are therefore difficult to make. Editors should initiate a consensus meeting to determine the outcome measures that should be used in clinical trials in reproductive medicine and formulate recommendations. These recommendations should be followed by authors to improve the overall quality of clinical research in reproductive medicine.
Conclusion
In conclusion, the use of the outcome measure singleton live birth, which was recommended by ESRHE in 2003, is not being implemented in clinical research. The use of singleton live birth as outcome reported in RCTs analysis. Manuscript drafting was done by M.B, E.I.K., F.M., B.W.M and F.v.d.V. All authors helped to prepare the final report.
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